Overview:

Summary

GlobalData’s new report, “Cyberonics, Inc. Market Share Analysis” provides in-depth information on Cyberonics, Inc.’s market position in the neurostimulation devices market. The report also provides data and information on the overall competitive landscape within the neurostimulation devices market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the neurostimulation devices market.
- Cyberonics, Inc.’s company shares (in Revenues) information for all the key countries the company has presence in – India, Japan, China, Australia, United Kingdom, France, Germany, Spain, Italy, United States, Canada and Brazil.
- Cyberonics, Inc.’s company shares (in Revenues) information for the neurostimulation devices market.
- All the key data-points are for 2010 and cover all the key regions – North America, Middle East and Africa, Europe, Asia-Pacific and South and Central America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Cyberonics, Inc.’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Cyberonics, Inc.’s market positions."

Companies Mentioned

Boston Scientific Corporation
Medtronic, Inc
Natus Medical Incorporated
NeuroMetrix, Inc.
Somanetics Corporation
St. Jude Medical, Inc

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
3 Definitions of Markets/Categories Covered 9
3.1 Neurostimulation Devices 9
4 Company Snapshot 10
4.1 Key Information 10
4.2 Company Overview 10
4.3 Financial Performance 10
4.4 Business Overview 11
4.5 Major Products and Services 12
4.5.1 Overview 12
5 History 13
6 Competitors 14
7 Competitive Landscape 15
7.1 Neurostimulation Devices Global, Market Share (%), 2010 15
8 Cyberonics, Inc. Medical Equipment Market Share Analysis 16
8.1 Cyberonics, Inc., Neurostimulation Devices, Global, Market Share (2010) 16
8.2 Cyberonics, Inc., Asia-Pacific, Market Share (2010) 17
8.3 Cyberonics, Inc., Europe, Market Share (2010) 18
8.4 Cyberonics, Inc., Middle East and Africa, Market Share (2010) 19
8.5 Cyberonics, Inc., North America, Market Share (2010) 20
8.6 Cyberonics, Inc., South and Central America, Market Share (2010) 21
9 Key Employees 22
10 Key Employee Biographies 23
11 Company Statement 24
12 Locations And Subsidiaries 26
12.1 Head Office 26
12.2 Other Locations & Subsidiaries 26
13 Financial Deals Landscape 28
13.1 Cyberonics, Inc., Deals Volume Summary, 2006 to YTD 2011 28
14 Cyberonics, Inc. Detailed Deal Summary 30
14.1 Partnerships 30
14.1.1 Cyberonics Enters Into Licensing Agreement With NeuroVista 30
14.1.2 Cyberonics Signs An Agreement With Ethicon Endo-Surgery 31
14.1.3 Cyberonics Signs An Agreement With Nihon Kohden 32
14.1.4 NeuroVista Secures $5 Million In Debt From Cyberonics 33
14.1.5 Cyberonics Completes Private Placement Of $125 Million 34
14.2 Acquisition 35
14.2.1 Boston Scientific Sells Its Stake In Cyberonics 35
15 Recent Developments 36
15.1 Strategy And Business Planning 36
15.1.1 Aug 24, 2010: Cyberonics Signs Epilepsy Technology Agreements With NeuroVista In Field Of EEG-based Seizure Detection 36
15.2 Financial Announcements 36
15.2.1 Mar 02, 2011: Cyberonics Reports Net Income Of $7.2m In Q3 Fiscal Year Ended 2011 36
15.2.2 Nov 22, 2010: Cyberonics Reports Net Income Of $24.9 Million For Q2 Fiscal 2011 37
15.2.3 Aug 25, 2010: Cyberonics Reports Net Income Of $7.16 Million In Q1 Fiscal 2011 38
15.2.4 Jun 02, 2010: Cyberonics Reports Net Sales Of $167.8 Million In Fiscal 2010 40
15.2.5 Nov 18, 2009: Cyberonics Reports Net Income Of $50.1 Million In Q2 Fiscal 2010 41
15.2.6 Aug 19, 2009: Cyberonics Posts Net Income Of $7.9 Million In Q1 Fiscal 2010 43
15.2.7 Jun 03, 2009: Cyberonics Posts Net Income Of $26.7 Million In Fiscal 2009 44
15.2.8 Feb 18, 2009: Cyberonics Reports Q3 Fiscal 2009 Results 46
15.2.9 Nov 19, 2008: Cyberonics Reports 2Q Fiscal 2009 Results 48
15.2.10 Aug 21, 2008: Cyberonics Reports 1Q Fiscal 2009 Results 49
15.2.11 Jun 11, 2008: Cyberonics Reports Q4 Fiscal 2008 Results 51
15.2.12 Feb 20, 2008: Cyberonics Declares Q3 Fiscal 2008 Results 53
15.2.13 Nov 19, 2007: Cyberonics Declares Q2 Fiscal 2008 Results 55
15.2.14 Aug 29, 2007: Cyberonics Reports Q1 Fiscal 2008 Results 57
15.2.15 Jun 11, 2007: Cyberonics Reports Fiscal Year 2007 Results 57
15.2.16 Feb 23, 2007: Cyberonics Reports Q3 Fiscal 2007 Results 58
15.3 Corporate Communications 58
15.3.1 Aug 09, 2010: Cyberonics Nominates Jon T. Tremmel To Stand As Director To Board 58
15.3.2 May 18, 2009: Cyberonics Appoints Bryan Olin As Vice President, Quality 59
15.3.3 Jan 12, 2009: Cyberonics Appoints Vice President, Research And Development 59
15.3.4 Aug 07, 2008: Cyberonics Nominates New Board Member 60
15.3.5 Jul 09, 2007: Cyberonics Appoints New CFO 60
15.3.6 May 01, 2007: Cyberonics Appoints New CEO 61
15.3.7 Jan 29, 2007: Cyberonics Announces Board Changes 61
15.4 Legal and Regulatory 61
15.4.1 Apr 21, 2008: Cyberonics Announces Settlement Of Convertible Note Litigation 61
15.5 Product News 62
15.5.1 Feb 01, 2011: Cyberonics Announces FDA Approval Of Aspire High Capacity Generator For VNS Therapy 62
15.5.2 Dec 21, 2010: Emory University School Of Medicine Presents Study Results Of Cyberonics’s VNS Therapy System 62
15.5.3 Nov 05, 2010: Cyberonics Confirms Safety And Efficacy Of VNS Therapy 63
15.5.4 Dec 04, 2009: Cyberonics' Vagus Nerve Stimulation (VNS) Therapy System To Be Featured At The AES Meeting 64
15.5.5 Jul 24, 2009: FDA Approves Cyberonics' Proposal To Amend The Protocol Of Its D-21 Post-Approval Dosing Study 65
15.5.6 Jan 07, 2009: Cyberonics Presents Business Updates On Depression Clinical Trial 65
15.5.7 Oct 01, 2008: Cyberonics Provides Update On Depression Indication 65
15.6 Other Significant Developments 66
15.6.1 Nov 21, 2008: Cyberonics To Present At Piper Jaffray Conference 66
15.6.2 Sep 15, 2008: Cyberonics Provides Operations Updates Following Hurricane Ike 66
15.6.3 Sep 11, 2008: Cyberonics’s CEO To Present At UBS Conference 66
15.6.4 Aug 26, 2008: Cyberonics To Present At Thomas Weisel Partners Healthcare Conference 66
15.6.5 Dec 18, 2007: Cyberonics Signs Agreement With Ethicon To License Its Patents Of Obesity Treatment 66
16 Appendix 68
16.1 Research Methodology 69
16.2 Secondary Research 69
16.3 Primary Research 70
16.4 Models 70
16.5 Forecasts 71
16.6 Expert Panels 71
16.7 GlobalData Consulting 71
16.8 Currency Conversion 72
16.9 Contact Us 73
16.10 Disclaimer 73"

1.1 List of Tables
Table 1:      Cyberonics, Inc., Key Facts, 2010 10
Table 2: Neurostimulation Devices, Global, Company Share by Revenue ($m), 2010 15
Table 3:      Cyberonics, Inc., Neurostimulation Devices, Global, Revenue ($m) and Market Share (%), 2010 16
Table 4:      Cyberonics, Inc., Neurostimulation Devices, Asia-Pacific, Revenue ($m) and Market Share (%), 2010 17
Table 5:      Cyberonics, Inc., Neurostimulation Devices, Europe, Revenue ($m) and Market Share (%), 2010 18
Table 6:      Cyberonics, Inc., Neurostimulation Devices, Middle East and Africa, Revenue ($m) and Market Share (%), 2010 19
Table 7:      Cyberonics, Inc., Neurostimulation Devices, North America, Revenue ($m) and Market Share (%), 2010 20
Table 8:      Cyberonics, Inc., Neurostimulation Devices, South and Central America, Revenue ($m) and Market Share (%), 2010 21
Table 9:      Cyberonics, Inc., Key Employees 22
Table 10:      Cyberonics, Inc., Other Locations 26
Table 11:      Cyberonics, Inc., Subsidiaries 27
Table 12:      Cyberonics, Inc., Deals Volume Summary, 2006 to YTD 2011 28
Table 13:      Cyberonics, Inc., Deals Summary, 2006 to YTD 2011 29
Table 14:      Cyberonics Enters Into Licensing Agreement With NeuroVista 30
Table 15:      Cyberonics Signs An Agreement With Ethicon Endo-Surgery 31
Table 16:      Cyberonics Signs An Agreement With Nihon Kohden 32
Table 17:      NeuroVista Secures $5 Million In Debt From Cyberonics 33
Table 18:      Cyberonics Completes Private Placement Of $125 Million 34
Table 19:      Boston Scientific Sells Its Stake In Cyberonics 35
Table 20:   USD to Local Currency, Average Exchange Rate, 2010 72"

1.2 List of Figures
Figure 1:      Neurostimulation Devices, Global, Market Share (%), 2010 15
Figure 2:      Cyberonics, Inc., Neurostimulation Devices Global, Market Share (%), 2010 16
Figure 3:      Cyberonics, Inc., Neurostimulation Devices, Asia-Pacific, Market Share (%), 2010 17
Figure 4:      Cyberonics, Inc., Neurostimulation Devices, Europe, Market Share (%), 2010 18
Figure 5:      Cyberonics, Inc., Neurostimulation Devices, North America, Market Share (%), 2010 20
Figure 6:      Cyberonics, Inc., Neurostimulation Devices, South and Central America, Market Share (%), 2010 21
Figure 7:      Cyberonics, Inc., Deals Volume Summary, 2006 to YTD 2011 28